Neurocognitive Impairment In Deficit And Non-deficit .
İİ
İłİİ
Neurocognitive impairment in de cit and non-de cit schizophreniaevidence for a distinct subtype of schizophreniacharacterized by pervasive cognitive deficit. AmericanJournal of Human Genetics 77, 468–476.Holliday EG, McLean DE, Nyholt DR, Mowry BJ (2009).Susceptibility locus on chromosome 1q23–25 for aschizophrenia subtype resembling deficit schizophreniaidentified by latent class analysis. Archives of GeneralPsychiatry 66, 1058–1067.Horan WP, Blanchard JJ (2003). Neurocognitive, social, andemotional dysfunction in deficit syndrome schizophrenia.Schizophrenia Research 65, 125–137.Kanahara N, Sekine Y, Haraguchi T, Uchida Y, HashimotoK, Shimizu E, Iyo M (2013). Orbitofrontal cortexabnormality and deficit schizophrenia. SchizophreniaResearch 143, 246–252.Kirkpatrick B, Buchanan RW, Breier A, Carpenter Jr WT(1994). Depressive symptoms and the deficit syndrome ofschizophrenia. Journal of Nervous and Mental Disease 182,452–455.Kirkpatrick B, Buchanan RW, Ross DE, Carpenter Jr WT(2001). A separate disease within the syndrome ofschizophrenia. Archives of General Psychiatry 58, 165–171.Lewandowski KE, Sperry SH, Cohen BM, Ongür D (2014).Cognitive variability in psychotic disorders: a crossdiagnostic cluster analysis. Psychological Medicine 44, 3239–3248.Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV,Seidman LJ (2009). Neurocognition in first-episodeschizophrenia: a meta-analytic review. Neuropsychology 23,315–336.Moberg PJ, Arnold SE, Doty RL, Gur RE, Balderston CC,Roalf DR, Gur RC, Kohler CG, Kanes SJ, Siegel SJ,Turetsky BI (2006). Olfactory functioning in schizophrenia:relationship to clinical, neuropsychological, and volumetricMRI measures. Journal of Clinical and ExperimentalNeuropsychology 28, 1444–1461.Moher D, Liberati A, Tetzlaff J, Altman DG, Group PRISMA(2009). Preferred reporting items for systematic reviews andmeta-analyses: the PRISMA statement. BMJ 339, b2535.Pegoraro LF, Dantas CR, Banzato CE, Fuentes D (2013).Correlation between insight dimensions and cognitivefunctions in patients with deficit and nondeficitschizophrenia. Schizophrenia Research 147, 91–94.Pełka-Wysiecka J, Wroński M, Bieńkowski P, Murawiec S,Samochowiec A, Samochowiec J (2016). Odorsidentification differences in deficit and nondeficitschizophrenia. Pharmacology Reports 68, 390–395.Peralta V, Moreno-Izco L, Sanchez-Torres A, García de JalónE, Campos MS, Cuesta MJ (2014). Characterization of thedeficit syndrome in drug-naive schizophrenia patients: therole of spontaneous movement disorders and neurologicalsoft signs. Schizophrenia Bulletin 40, 214–224.Polgár P, Farkas M, Nagy O, Kelemen O, Réthelyi J, Bitter I,Myers CE, Gluck MA, Kéri S (2008). How to find the wayout from four rooms? The learning of “chaining”associations may shed light on the neuropsychology of thedeficit syndrome of schizophrenia. Schizophrenia Research99, 200–207.2413Putnam KM, Harvey PD (2000). Cognitive impairment andenduring negative symptoms: a comparative study ofgeriatric and nongeriatric schizophrenia patients.Schizophrenia Bulletin 26, 867–878.Réthelyi JM, Czobor P, Polgár P, Mersich B, Bálint S, JekkelE, Magyar K, Mészáros A, Fábián A, Bitter I (2012).General and domain-specific neurocognitive impairmentsin deficit and non-deficit schizophrenia. European Archives ofPsychiatry and Clinical Neurosciences 262, 107–115.Seckinger RA, Goudsmit N, Coleman E, Harkavy-FriedmanJ, Yale S, Rosenfield PJ, Malaspina D (2004). Olfactoryidentification and WAIS-R performance in deficit andnondeficit schizophrenia. Schizophrenia Research 69, 55–65.Strauss GP, Allen DN, Ross SA, Duke LA, Schwartz J(2010a). Olfactory hedonic judgment in patients with deficitsyndrome schizophrenia. Schizophrenia Bulletin 36, 860–868.Strauss GP, Jetha SS, Ross SA, Duke LA, Allen DN (2010b).Impaired facial affect labeling and discrimination inpatients with deficit syndrome schizophrenia. SchizophreniaResearch 118, 146–153.Tang XW, Yu M, Duan WW, Zhang XR, Sha WW, Wang X,Zhang XB (2016). Facial emotion recognition andalexithymia in Chinese male patients with deficitschizophrenia. Psychiatry Research 246, 353–359.Tiryaki A, Yazici MK, Anil AE, Kabakçi E, Karaağaoğlu E,Göğüş A (2003). Reexamination of the characteristics of thedeficit schizophrenia patients. European Archives ofPsychiatry and Clinical Neurosciences 253, 221–227.Ventura J, Wood RC, Hellemann GS (2013). Symptomdomains and neurocognitive functioning can helpdifferentiate social cognitive processes in schizophrenia: ameta-analysis. Schizophrenia Bulletin 39, 102–111.Viechtbauer W (2010). Conducting meta-analyses in R withthe metafor package. Journal of Statistical Softwares 36, 1–48.Voineskos AN, Foussias G, Lerch J, Felsky D, Remington G,Rajji TK, Lobaugh N, Pollock BG, Mulsant BH (2013).Neuroimaging evidence for the deficit subtype ofschizophrenia. JAMA Psychiatry 70, 472–480.Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P,Schmid CH (2012). Closing the gap betweenmethodologists and end-users: R as a computational backend. Journal of Statistical Softwares 49, 1–15.Wang X, Yao S, Kirkpatrick B, Shi C, Yi J (2008).Psychopathology and neuropsychological impairments indeficit and nondeficit schizophrenia of Chinese origin.Psychiatry Research 158, 195–205.Wheeler AL, Wessa M, Szeszko PR, Foussias G,Chakravarty MM, Lerch JP, DeRosse P, Remington G,Mulsant BH, Linke J, Malhotra AK, Voineskos AN (2015).Further neuroimaging evidence for the deficit subtype ofschizophrenia: a cortical connectomics analysis. JAMAPsychiatry 72, 446–455.Yu M, Tang X, Wang X, Zhang X, Zhang X, Sha W, Yao S,Shu N, Zhang X, Zhang Z (2015). Neurocognitiveimpairments in deficit and non-deficit schizophreniaand their relationships with symptom dimensionsand other clinical variables. PLoS ONE 10,e0138357.Downloaded from https://www.cambridge.org/core, on subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291717000952
Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis E. Bora1,2*, B. Binnur Akdede 2and K. Alptekin 1Department of Psychiatry, Dokuz Eylul University School of Medicine, Izmir, Turkey 2Department of Psychiatry, Melbourne Neuropsychiatry Centre, University of Melbourne and Melbourne H
CIT 145 Perl I CIT 146 Swift I CIT 237 iOS Programming CIT 238 Android Programming CIT 241 PHP II CIT 242 C II Approved Level II Programming Language Courses INF 120 Elementary Programming Course CIT 144 Python I CIT 148 Visual Basic I Approved Level I Programming Language Courses CIT
wat e r for texas 2012 at at lan. 205. chapter 8: impacts of plans. bacteria impairment bacteria impairment for oysters dissolved oxygen impairment toxicity impairment ph impairment biological integrity impairment dissolved solids impairment metals impairment organics impairment nitrate and nitrite impairment. figure 8.1.
Wells Fargo Enhanced Stock Market CIT 101 Wells Fargo Factor Enhanced Large Cap Core CIT (formerly, Wells Fargo Factor Enhanced Large Cap Index CIT) 107 Wells Fargo Fundamental Small Cap Growth CIT 123 Wells Fargo Growth CIT 126 Wells Fargo Large Cap Intrinsic Value CIT 129 Wells Fargo Liability Driven Solution CIT I 131
clients. CIT relies upon Corporate Function employees provided by CITBNA and CIT Group (NJ) LLC ("CIT NJ") for centralized corporate and administrative services, including certain members of CIT's executive management team. CIT has entered into a mutual services agreement with CITBNA that allows for the provision and receipt of general .
CIT-1, CIT-A, CIT-B, CIT-C, Vouchers - 1 - www.tax.newmexico.gov Contact Information You can contact the Department by mail, email, or phone. New Mexico Taxation and Revenue Department Corporate Income and Franchise Tax P. O. Box 25127 Santa Fe, NM 87504-5127 CIT.TaxReturnHelp@state.nm.us
associated with the impairment test, the impairment-only approach may be favoured by users in providing information about the success of business combinations and avoiding arbitrary amortisation expenses. However, the Board also noted that an impairment test would be required under both the impairment-only and amortisation approaches.
An impairment test must be undertaken if there are indications of impairment. Consequently, the identification of indicators of impairment becomes a crucial stage in the process. IAS 36 provides guidance in the form of a list of internal and external indicators of impairment. It stresses that this list is the
Send comments (with copy to psa@ansi.org) to: Christina Earl, (315) 339-6937, cearl@esda.org TCIA (ASC A300) (Tree Care Industry Association) Revision BSR A300 (Part 3)-201x, Tree Care Operations - Tree, Shrub, and Other Woody Plant Management - Standard Practices (Supplemental Support Systems) (revision of ANSI A300 (Part 3)-2006)
